Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDJune 5, 2025
Allay Therapeutics’ Phase 2B Clinical Study Supports Ability of ATX101 To Deliver Four Weeks of Sustained Post-surgical Pain Relief
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDApril 11, 2024
Allay Therapeutics Announces Development and Commercialization Agreement with Maruishi Pharmaceutical
Allay Therapeutics, Inc. (Allay) today announced that they have entered into a license agreement with…
Arboretum_JDDecember 18, 2023
Allay Therapeutics Appoints Nicole Vitullo to Board Of Directors
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDSeptember 6, 2023
Allay Therapeutics Completes Oversubscribed $60M Financing Led by Arboretum Ventures
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management…
Arboretum_JDSeptember 15, 2021
